Talk:SARS-CoV-2 Kappa variant
Latest comment: 3 years ago by SpookiePuppy in topic Notability
| This is the talk page for discussing improvements to the SARS-CoV-2 Kappa variant article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to multiple WikiProjects. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
.svg){kind=small}
 | The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
Notability
editThis article has been created to assist with the renaming of Lineage B.1.617 which will almost certainly involve the splitting off of the sublineages and the disentangling of sublineage B.1.617.2 from B.1.617.1. Under other circumstances, the sublineage B.1.617.1 would probably not have been notable enough to justify its own article. SpookiePuppy (talk) 00:35, 7 June 2021 (UTC)